Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Phase 3 Colorectal Cancer Trials

9 Phase 3 trials for Colorectal Cancer. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.

What is a Phase 3 trial?

Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
RECRUITINGPhase 3NCT03925662

Mebendazole as Adjuvant Treatment for Colon Cancer

mebendazole treating colon cancer

Sponsor: Sherief Abd-ElsalamEnrolling: 401 location
RECRUITINGPhase 3NCT06293625

Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of...

Colon cancer (CC) is the 5th most common cancer worldwide. Standard care for locally advanced disease is surgical resection followed by 3-6 months of adjuvant chemotherapy (AC)...

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 1501 location
RECRUITINGPhase 3NCT06107920

Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy

The aim of this study is to determine whether chemotherapy prior to tumor removal (neoadjuvant chemotherapy), in patients undergoing treatment for colon cancer in occlusion (CCO),...

Sponsor: University Hospital, RouenEnrolling: 23220 locations
RECRUITINGPhase 3NCT06252649

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve...

The aim of this study is to compare progression free survival (PFS) in treatment-naïve participants with KRAS p.G12C mutated metastatic colorectal cancer (mCRC) receiving...

Sponsor: AmgenEnrolling: 45020 locations
RECRUITINGPhase 3NCT05236972

PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer

In this open-label phase III study, patients with local advanced colon cancer (TanyN+ ,M0, dMMR/MSI-H, at least 10cm from the anus verge)will be scheduled to Group A: receive...

Sponsor: Sun Yat-sen UniversityEnrolling: 3231 location
RECRUITINGPhase 3NCT06951503

AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

This trial is a Phase III study. The purpose of this study is to evaluate the efficacy and safety of AK112 and chemotherapy versus bevacizumab and chemotherapy for the first-line...

Sponsor: AkesoEnrolling: 5602 locations
RECRUITINGPhase 3NCT06662786

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in...

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil,...

Sponsor: Janssen Research & Development, LLCEnrolling: 100020 locations
RECRUITINGPhase 3NCT06862115

The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult...

The aim of this study is to estimate the effect of discontinuation of RAS inhibitors on myocardial injury in cancer patients undergoing major abdominal surgeries.

Sponsor: Kasr El Aini HospitalEnrolling: 1561 location
RECRUITINGPhase 3NCT06139926

Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients...

Currently, domestic and international research on dexmedetomidine as well as anxiety and depression is more focused on basic research. In terms of clinical research,...

Sponsor: First Affiliated Hospital of Chongqing Medical UniversityEnrolling: 1261 location